Lawler CP - Search Results

1

Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.

Lewis MM, Watts VJ, Lawler CP, Nichols DE, Mailman RB. Lewis MM, et al. Among authors: lawler cp. J Pharmacol Exp Ther. 1998 Jul;286(1):345-53. J Pharmacol Exp Ther. 1998. PMID: 9655879

2

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.

Mottola DM, Kilts JD, Lewis MM, Connery HS, Walker QD, Jones SR, Booth RG, Hyslop DK, Piercey M, Wightman RM, Lawler CP, Nichols DE, Mailman RB. Mottola DM, et al. Among authors: lawler cp. J Pharmacol Exp Ther. 2002 Jun;301(3):1166-78. doi: 10.1124/jpet.301.3.1166. J Pharmacol Exp Ther. 2002. PMID: 12023552

3

Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs.

Kilts JD, Connery HS, Arrington EG, Lewis MM, Lawler CP, Oxford GS, O'Malley KL, Todd RD, Blake BL, Nichols DE, Mailman RB. Kilts JD, et al. Among authors: lawler cp. J Pharmacol Exp Ther. 2002 Jun;301(3):1179-89. doi: 10.1124/jpet.301.3.1179. J Pharmacol Exp Ther. 2002. PMID: 12023553

4

"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications.

Gilmore JH, Watts VJ, Lawler CP, Noll EP, Nichols DE, Mailman RB. Gilmore JH, et al. Among authors: lawler cp. Neuropharmacology. 1995 May;34(5):481-8. doi: 10.1016/0028-3908(95)00014-w. Neuropharmacology. 1995. PMID: 7566481

5

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.

Watts VJ, Lawler CP, Fox DR, Neve KA, Nichols DE, Mailman RB. Watts VJ, et al. Among authors: lawler cp. Psychopharmacology (Berl). 1995 Apr;118(4):401-9. doi: 10.1007/BF02245940. Psychopharmacology (Berl). 1995. PMID: 7568626

6

Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.

Watts VJ, Lawler CP, Gilmore JH, Southerland SB, Nichols DE, Mailman RB. Watts VJ, et al. Among authors: lawler cp. Eur J Pharmacol. 1993 Sep 28;242(2):165-72. doi: 10.1016/0014-2999(93)90076-t. Eur J Pharmacol. 1993. PMID: 7902811

7

Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.

Watts VJ, Lawler CP, Knoerzer T, Mayleben MA, Neve KA, Nichols DE, Mailman RB. Watts VJ, et al. Among authors: lawler cp. Eur J Pharmacol. 1993 Aug 3;239(1-3):271-3. doi: 10.1016/0014-2999(93)91012-c. Eur J Pharmacol. 1993. PMID: 8223910

8

Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists.

Watts VJ, Lawler CP, Gonzales AJ, Zhou QY, Civelli O, Nichols DE, Mailman RB. Watts VJ, et al. Among authors: lawler cp. Synapse. 1995 Oct;21(2):177-87. doi: 10.1002/syn.890210211. Synapse. 1995. PMID: 8584979

9

Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.

Lawler CP, Gilmore JH, Watts VJ, Walker QD, Southerland SB, Cook LL, Mathis CA, Mailman RB. Lawler CP, et al. Synapse. 1995 Dec;21(4):299-311. doi: 10.1002/syn.890210404. Synapse. 1995. PMID: 8869160

10

Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.

Smith HP, Nichols DE, Mailman RB, Lawler CP. Smith HP, et al. Among authors: lawler cp. Eur J Pharmacol. 1997 Mar 26;323(1):27-36. doi: 10.1016/s0014-2999(97)00026-5. Eur J Pharmacol. 1997. PMID: 9105873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters